CB
CBD Life Sciences Inc.
CBDL · OTC
$0.00 +0.00% (+$0.00)
1M +33.33%
Market Cap $375.4K
P/E Ratio -
Div. Yield -
ROE 8.50%
Piotroski F-Score Weak
2/9Valuation
73 /100
Cheap P/B 0.49x
P/S 3.82x
PEG N/A
Growth
22 /100
Declining Book val. growth 17.46%
Rev. growth 15.03%
FCF growth N/A
Profitability
17 /100
Weak FCF margin 141.53%
Op. margin 103.44%
Gross margin 42.20%
Quality
2 /100
Poor Asset turnover 0.12x
ROA 6.08%
ROIC 13.26%
Debt
100 /100
Low Current ratio 15.12x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
30 /100
Unstable Profitable years 0
EPS volatility 164.43%
Beta -0.59x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CBDL
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lisa Anne Nelson
Employees
3
Headquarters
Scottsdale